Human Phenotype Ontology 
Grandparent Node:
expand
Phenotypic abnormality (HP:0000118)help
Parent Node:
expand
Abnormality of metabolism/homeostasis (HP:0001939)help
..Starting node
..expand
Bloodstream infectious agent (HP:0031863)help
Term ID: 31863
Name: Bloodstream infectious agent
Synonym:
Definition: The presence of an infectious agent in the blood circulation.
Comments:
Reference: HP:0031863
Genes and Diseases:
 
       Child Nodes:
........expandBacteremia (HP:0031864) help

 Sister Nodes: 
..expandAbnormal blood ion concentration (HP:0003111) help
..expandAbnormal calcium-phosphate regulating hormone level (HP:0100530) help
..expandAbnormal cellular physiology (HP:0011017) help
..expandAbnormal circulating carbohydrate concentration (HP:0011013) help
..expandAbnormal circulating carboxylic acid concentration (HP:0004354) help
..expandAbnormal circulating lipid concentration (HP:0003119) help
..expandAbnormal circulating nitrogen compound concentration (HP:0004364) help
..expandAbnormal circulating nucleobase concentration (HP:0010932) help
..expandAbnormal circulating porphyrin concentration (HP:0010472) help
..expandAbnormal circulating protein concentration (HP:0010876) help
..expandAbnormal circulating selenium concentration (HP:0031903) help
..expandAbnormal enzyme/coenzyme activity (HP:0012379) help
..expandAbnormal erythrocyte sedimentation rate (HP:0025021) help
..expandAbnormal homeostasis (HP:0012337) help
..expandAbnormal sweat homeostasis (HP:0040127) help
..expandAbnormality of acid-base homeostasis (HP:0004360) help
..expandAbnormality of fluid regulation (HP:0011032) help
..expandAbnormality of Krebs cycle metabolism (HP:0000816) help
..expandAbnormality of superoxide metabolism (HP:0004358) help
..expandAbnormality of temperature regulation (HP:0004370) help
..expandAbnormality of urine homeostasis (HP:0003110) help
..expandAbnormality of vitamin metabolism (HP:0100508) help
..expandAmyloidosis (HP:0011034) help
..expandFood intolerance (HP:0012537) help
..expandGangrene (HP:0100758) help
..expandHyperbilirubinemia (HP:0002904) help
..expandIncreased level of propylene glycol in blood (HP:0410069) help
..expandKetosis (HP:0001946) help
..expandMolybdenum cofactor deficiency (HP:0003570) help
..expandobsolete Abnormality of glycoprotein metabolism (HP:0004367) help
..expandPresence of xenobiotic (HP:0031838) help
..expandReduced 5-oxoprolinase level (HP:0040142) help
..expandReduced acetaldehyde dehydrogenase level (HP:0003533) help
..expandReduced glutathione synthetase level (HP:0003343) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0031863HP:0031863Bloodstream infectious agent0CD27 CL E G H93911922OMIM:615122Lymphoproliferative syndrome 24
HP:0031863HP:0031863Bloodstream infectious agent0CTPS1 CL E G H15032519OMIM:615897IMMUNODEFICIENCY 24; IMD242
HP:0031863HP:0031863Bloodstream infectious agent0DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0031863HP:0031863Bloodstream infectious agent0ELANE CL E G H19913309ORPHA:2686Cyclic neutropenia79
HP:0031863HP:0031863Bloodstream infectious agent0IKZF3 CL E G H2280613178OMIM:619437IMMUNODEFICIENCY 84; IMD84
HP:0031863HP:0031863Bloodstream infectious agent0IL2RB CL E G H35606009OMIM:618495Immunodeficiency 63 with lymphoproliferation and autoimmunity
HP:0031863HP:0031863Bloodstream infectious agent0ITK CL E G H37026171OMIM:613011LYMPHOPROLIFERATIVE SYNDROME 1; LPFS151
HP:0031863HP:0031863Bloodstream infectious agent0LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0031863HP:0031863Bloodstream infectious agent0MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031863HP:0031863Bloodstream infectious agent0PGM3 CL E G H52388907OMIM:615816Immunodeficiency 2315
HP:0031863HP:0031863Bloodstream infectious agent0PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0031863HP:0031863Bloodstream infectious agent0PRKCD CL E G H55809399OMIM:615559AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS310
HP:0031863HP:0031863Bloodstream infectious agent0REL CL E G H59669954OMIM:619652IMMUNODEFICIENCY 92; IMD921
HP:0031863HP:0031863Bloodstream infectious agent0TET2 CL E G H5479025941OMIM:619126IMMUNODEFICIENCY 75; IMD753
HP:0031863HP:0031863Bloodstream infectious agent0TOM1 CL E G H1004311982OMIM:619510IMMUNODEFICIENCY 85 AND AUTOIMMUNITY; IMD85
HP:0031863HP:0031863Bloodstream infectious agent0TPP2 CL E G H717412016OMIM:619220IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78
HP:0031863HP:0020071Viremia1CD27 CL E G H93911922OMIM:615122Lymphoproliferative syndrome 24
HP:0031863HP:0020071Viremia1CTPS1 CL E G H15032519OMIM:615897IMMUNODEFICIENCY 24; IMD242
HP:0031863HP:0020071Viremia1DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0031863HP:0031864Bacteremia1ELANE CL E G H19913309ORPHA:2686Cyclic neutropeniaHP:0040284 - Very rare79
HP:0031863HP:0020071Viremia1IKZF3 CL E G H2280613178OMIM:619437IMMUNODEFICIENCY 84; IMD84
HP:0031863HP:0020071Viremia1IL2RB CL E G H35606009OMIM:618495Immunodeficiency 63 with lymphoproliferation and autoimmunity
HP:0031863HP:0020071Viremia1ITK CL E G H37026171OMIM:613011LYMPHOPROLIFERATIVE SYNDROME 1; LPFS151
HP:0031863HP:0020071Viremia1LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0031863HP:0020071Viremia1MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031863HP:0020071Viremia1PGM3 CL E G H52388907OMIM:615816Immunodeficiency 2315
HP:0031863HP:0020071Viremia1PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0031863HP:0020071Viremia1PRKCD CL E G H55809399OMIM:615559AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS310
HP:0031863HP:0020071Viremia1REL CL E G H59669954OMIM:619652IMMUNODEFICIENCY 92; IMD921
HP:0031863HP:0020071Viremia1TET2 CL E G H5479025941OMIM:619126IMMUNODEFICIENCY 75; IMD753
HP:0031863HP:0020071Viremia1TOM1 CL E G H1004311982OMIM:619510IMMUNODEFICIENCY 85 AND AUTOIMMUNITY; IMD85
HP:0031863HP:0020071Viremia1TPP2 CL E G H717412016OMIM:619220IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78
HP:0031863HP:0032248Persistent viremia2CD27 CL E G H93911922OMIM:615122Lymphoproliferative syndrome 24
HP:0031863HP:0032248Persistent viremia2CTPS1 CL E G H15032519OMIM:615897IMMUNODEFICIENCY 24; IMD242
HP:0031863HP:0032248Persistent viremia2DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0031863HP:0032248Persistent viremia2IKZF3 CL E G H2280613178OMIM:619437IMMUNODEFICIENCY 84; IMD84
HP:0031863HP:0032248Persistent viremia2IL2RB CL E G H35606009OMIM:618495Immunodeficiency 63 with lymphoproliferation and autoimmunity
HP:0031863HP:0032248Persistent viremia2ITK CL E G H37026171OMIM:613011LYMPHOPROLIFERATIVE SYNDROME 1; LPFS151
HP:0031863HP:0032248Persistent viremia2LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0031863HP:0032248Persistent viremia2MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031863HP:0032248Persistent viremia2PGM3 CL E G H52388907OMIM:615816Immunodeficiency 2315
HP:0031863HP:0032248Persistent viremia2PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0031863HP:0032248Persistent viremia2PRKCD CL E G H55809399OMIM:615559AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS310
HP:0031863HP:0032248Persistent viremia2REL CL E G H59669954OMIM:619652IMMUNODEFICIENCY 92; IMD921
HP:0031863HP:0032248Persistent viremia2TET2 CL E G H5479025941OMIM:619126IMMUNODEFICIENCY 75; IMD753
HP:0031863HP:0032248Persistent viremia2TOM1 CL E G H1004311982OMIM:619510IMMUNODEFICIENCY 85 AND AUTOIMMUNITY; IMD85
HP:0031863HP:0032248Persistent viremia2TPP2 CL E G H717412016OMIM:619220IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78
HP:0031863HP:0020072Persistent EBV viremia3CD27 CL E G H93911922OMIM:615122Lymphoproliferative syndrome 24
HP:0031863HP:0020072Persistent EBV viremia3DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0031863HP:0020072Persistent EBV viremia3IKZF3 CL E G H2280613178OMIM:619437IMMUNODEFICIENCY 84; IMD84
HP:0031863HP:0032247Persistent CMV viremia3IL2RB CL E G H35606009OMIM:618495Immunodeficiency 63 with lymphoproliferation and autoimmunity
HP:0031863HP:0020072Persistent EBV viremia3ITK CL E G H37026171OMIM:613011LYMPHOPROLIFERATIVE SYNDROME 1; LPFS151
HP:0031863HP:0020072Persistent EBV viremia3LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0031863HP:0032247Persistent CMV viremia3LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0031863HP:0032247Persistent CMV viremia3MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031863HP:0020072Persistent EBV viremia3MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031863HP:0020072Persistent EBV viremia3PGM3 CL E G H52388907OMIM:615816Immunodeficiency 2315
HP:0031863HP:0032247Persistent CMV viremia3PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0031863HP:0020072Persistent EBV viremia3PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0031863HP:0020072Persistent EBV viremia3PRKCD CL E G H55809399OMIM:615559AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS310
HP:0031863HP:0032247Persistent CMV viremia3REL CL E G H59669954OMIM:619652IMMUNODEFICIENCY 92; IMD921
HP:0031863HP:0020072Persistent EBV viremia3TET2 CL E G H5479025941OMIM:619126IMMUNODEFICIENCY 75; IMD753
HP:0031863HP:0020072Persistent EBV viremia3TOM1 CL E G H1004311982OMIM:619510IMMUNODEFICIENCY 85 AND AUTOIMMUNITY; IMD85
HP:0031863HP:0032247Persistent CMV viremia3TPP2 CL E G H717412016OMIM:619220IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78


Genes (16) :CD27 CTPS1 DEF6 ELANE IKZF3 IL2RB ITK LAT MAGT1 PGM3 PIK3R1 PRKCD REL TET2 TOM1 TPP2

Diseases (16) :OMIM:615122 OMIM:615897 OMIM:619573 ORPHA:2686 OMIM:619437 OMIM:618495 OMIM:613011 OMIM:617514 OMIM:300853 OMIM:615816 OMIM:616005 OMIM:615559 OMIM:619652 OMIM:619126 OMIM:619510 OMIM:619220
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.